These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Impact of selective prostaglandin E1 treatment on graft perfusion and function after liver transplantation. Kornberg A; Schotte U; Kupper B; Hommann M; Scheele J Hepatogastroenterology; 2004; 51(56):526-31. PubMed ID: 15086195 [TBL] [Abstract][Full Text] [Related]
6. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report. Sinclair SB; Greig PD; Blendis LM; Abecassis M; Roberts EA; Phillips MJ; Cameron R; Levy GA J Clin Invest; 1989 Oct; 84(4):1063-9. PubMed ID: 2794044 [TBL] [Abstract][Full Text] [Related]
8. Treating ischaemia-reperfusion injury with prostaglandin E1 reduces the risk of early hepatocellular carcinoma recurrence following liver transplantation. Kornberg A; Witt U; Kornberg J; Friess H; Thrum K Aliment Pharmacol Ther; 2015 Nov; 42(9):1101-10. PubMed ID: 26282466 [TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E1 for the treatment of primary non-function of the donor organ in liver transplantation. Mollison LC; Angus PW; Jones RM Med J Aust; 1991 Jul; 155(1):51-3. PubMed ID: 2067441 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of intraportal infusion of prostaglandin E1 to improve the hepatic blood flow and graft viability in porcine liver transplantation. Kawachi S; Shimazu M; Wakabayashi G; Tanabe M; Shirasugi N; Kumamoto Y; Karahashi T; Yoshida M; Kitajima M Transplantation; 1997 Jul; 64(2):205-9. PubMed ID: 9256174 [TBL] [Abstract][Full Text] [Related]
11. Successful reversal of primary graft non-function in a liver transplant patient treated with prostaglandin E1. Isai H; Sheil AG; McCaughan G; Dolan P; Waugh R Aust N Z J Surg; 1992 Apr; 62(4):314-6. PubMed ID: 1550525 [TBL] [Abstract][Full Text] [Related]
12. Plasma prostaglandin E1 concentrations and hemodynamics during intravenous infusions of prostaglandin E1 in humans and swine. Awas JA; Soteriou MC; Drougas JG; Stokes KA; Roberts LJ; Pinson CW Transplantation; 1996 Jun; 61(11):1624-9. PubMed ID: 8669108 [TBL] [Abstract][Full Text] [Related]
13. Differentiated therapy with prostaglandin E1 (alprostadil) after orthotopic liver transplantation: the usefulness of procalcitonin (PCT) and hepatic artery resistive index (RI) for the evaluation of early graft function and clinical course. Kornberg A; Grube T; Wagner T; Voigt R; Homman M; Schotte U; Schmidt K; Scheele J Clin Chem Lab Med; 2000 Nov; 38(11):1177-80. PubMed ID: 11156354 [TBL] [Abstract][Full Text] [Related]
14. Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation. Gluckman E; Jolivet I; Scrobohaci ML; Devergie A; Traineau R; Bourdeau-Esperou H; Lehn P; Faure P; Drouet L Br J Haematol; 1990 Mar; 74(3):277-81. PubMed ID: 2159315 [TBL] [Abstract][Full Text] [Related]
15. Prostaglandins in liver transplantation. Merion RM Adv Exp Med Biol; 1997; 433():13-8. PubMed ID: 9561096 [TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E1 increases survival with extended anhepatic phase during liver transplantation. Xu HS; Rosenlof LK; Pruett TL; Jones RS Ann Surg; 1994 Jul; 220(1):53-8. PubMed ID: 8024359 [TBL] [Abstract][Full Text] [Related]
17. Treatment of fulminant viral hepatic failure with prostaglandin E. A preliminary report. Sinclair SB; Levy GA Dig Dis Sci; 1991 Jun; 36(6):791-800. PubMed ID: 1903342 [TBL] [Abstract][Full Text] [Related]
18. The effects of long-term graft preservation on intraoperative hemostatic changes in liver transplantation. A comparison between orthotopic and heterotopic transplantation in the pig. Bakker CM; Blankensteijn JD; Schlejen P; Porte RJ; Gomes MJ; Lampe HI; Stibbe J; Terpstra OT HPB Surg; 1994; 7(4):265-80. PubMed ID: 8204546 [TBL] [Abstract][Full Text] [Related]
19. [The effect of low-dose prostaglandin E1 on intra- and post-operative liver function]. Hayashida M; Hanaoka K; Shimada Y; Namiki A; Amaha K Masui; 1997 May; 46(5):618-27. PubMed ID: 9185458 [TBL] [Abstract][Full Text] [Related]
20. [A trial use of prostaglandin E1 for prevention of hepatic veno-occlusive disease after allogeneic bone marrow transplantation]. Morio S; Oh H; Kogure K; Ishii H; Ishii A; Nakaseko C; Ikegami T; Kawano E; Matsuura Y; Nishimura M Rinsho Ketsueki; 1994 Sep; 35(9):846-52. PubMed ID: 7967053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]